Amer Shared Hosp Financials
Amer Shared Hosp (AMS) reported $28.1M in revenue for fiscal year 2025, down 0.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
American Shared Hospital Services looks like a capital-heavy operator whose cash cushion shrank as unit economics weakened materially.
Recently, headline deleveraging did not create balance-sheet slack: long-term debt fell to$0 while cash dropped to$3.5M . The real shift was toward near-term pressure, with the current ratio sliding from 2.5x to 0.8x, so lower leverage on paper came with less day-to-day liquidity.
Volume was not the main problem: revenue held near
Cash conversion was better than the income statement alone suggests, as the latest year turned a net loss of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Amer Shared Hosp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Amer Shared Hosp has an operating margin of -12.8%, meaning the company loses $13 on every $100 of revenue. This results in a profitability score of 17/100. This is down from -9.9% the prior year.
Amer Shared Hosp's revenue declined 0.9% year-over-year, from $28.3M to $28.1M. This contraction results in a growth score of 75/100.
Amer Shared Hosp carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
Amer Shared Hosp's current ratio of 0.76 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Amer Shared Hosp generated $3.1M in operating cash flow, capex of $7.6M consumed most of it, leaving -$4.5M in free cash flow. This results in a low score of 13/100, reflecting heavy capital investment rather than weak cash generation.
Amer Shared Hosp posts a -6.5% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 19/100. This is down from 8.7% the prior year.
Amer Shared Hosp scores 0.48, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Amer Shared Hosp passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Amer Shared Hosp reported a net loss of $1.6M while generating $3.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Amer Shared Hosp reported an operating loss of $3.6M against $1.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Amer Shared Hosp generated $28.1M in revenue in fiscal year 2025. This represents a decrease of 0.9% from the prior year.
Amer Shared Hosp's EBITDA was $2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 36.9% from the prior year.
Amer Shared Hosp reported -$1.6M in net income in fiscal year 2025. This represents a decrease of 171.0% from the prior year.
Amer Shared Hosp earned -$0.23 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 169.7% from the prior year.
Cash & Balance Sheet
Amer Shared Hosp recorded an outflow of $4.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 41.6% from the prior year.
Amer Shared Hosp held $3.5M in cash against $0 in long-term debt as of fiscal year 2025, with $23.4M of liabilities due within a year.
Not reported for fiscal year 2025.
Margins & Returns
Amer Shared Hosp's gross margin was 18.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 14.4 percentage points from the prior year.
Amer Shared Hosp's operating margin was -12.8% in fiscal year 2025, reflecting core business profitability. This is down 2.9 percentage points from the prior year.
Amer Shared Hosp's net profit margin was -5.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 13.2 percentage points from the prior year.
Amer Shared Hosp's ROE was -6.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 15.1 percentage points from the prior year.
Capital Allocation
Amer Shared Hosp invested $7.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.8% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
AMS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.4M | $28.1M-0.9% | $28.3M+32.9% | $21.3M+8.0% | $19.7M+12.0% | $17.6M-1.2% | $17.8M-13.4% | $20.6M+4.5% | $19.7M+0.8% | $19.6M+4.6% | $18.7M+13.0% | $16.5M+7.3% | $15.4M-12.3% | $17.6M+3.1% | $17.0M-23.3% | $22.2M |
| Cost of Revenue | $25.2M | $23.0M+20.2% | $19.2M+59.9% | $12.0M+5.4% | $11.4M+4.2% | $10.9M-18.5% | $13.4M | N/A | $12.2M+12.3% | $10.9M+10.0% | $9.9M+0.7% | $9.8M-3.0% | $10.1M-4.7% | $10.6M+5.2% | $10.1M-28.9% | $14.2M |
| Gross Profit | $5.2M | $5.1M-44.9% | $9.2M-1.7% | $9.3M+11.5% | $8.4M+24.6% | $6.7M+50.6% | $4.5M-35.5% | $6.9M-7.6% | $7.5M-13.6% | $8.7M-1.5% | $8.8M+31.0% | $6.7M+27.2% | $5.3M-24.0% | $6.9M+0.2% | $6.9M-13.3% | $8.0M |
| SG&A Expenses | $7.5M | $7.1M-4.4% | $7.4M+5.5% | $7.0M+36.5% | $5.1M+13.6% | $4.5M-1.7% | $4.6M+13.5% | $4.1M+1.7% | $4.0M-7.6% | $4.3M+13.7% | $3.8M+8.8% | $3.5M-3.7% | $3.6M-9.8% | $4.0M-0.5% | $4.0M+0.1% | $4.0M |
| Operating Income | -$3.6M | -$3.6M-27.9% | -$2.8M-1138.9% | $270K-88.9% | $2.4M+79.9% | $1.4M+114.3% | -$9.5M-713.7% | $1.5M-17.1% | $1.9M-22.9% | $2.4M-26.6% | $3.3M+66.0% | $2.0M+4060.0% | -$50K-104.5% | $1.1M+53.4% | $730K-54.1% | $1.6M |
| Interest Expense | $1.3M | $1.6M+5.0% | $1.5M+34.8% | $1.1M+38.0% | $806K+9.1% | $739K-30.1% | $1.1M-19.8% | $1.3M-19.2% | $1.6M-15.4% | $1.9M+12.9% | $1.7M+37.8% | $1.2M-27.1% | $1.7M-5.6% | $1.8M-16.5% | $2.2M-9.0% | $2.4M |
| Income Tax | $78K | -$493K-67.1% | -$295K-168.4% | $431K-55.2% | $963K+258.0% | $269K+115.5% | -$1.7M-1457.0% | $128K-71.6% | $451K+140.9% | -$1.1M-217.0% | $943K+117.3% | $434K+236.4% | $129K+53.6% | $84K-21.5% | $107K-48.6% | $208K |
| Net Income | -$1.8M | -$1.6M-171.0% | $2.2M+258.4% | $610K-54.1% | $1.3M+584.5% | $194K+102.7% | -$7.1M-1171.0% | $659K-35.6% | $1.0M-46.8% | $1.9M+106.8% | $930K+161.1% | -$1.5M-59.9% | -$952K-205.1% | -$312K-921.1% | $38K-92.5% | $506K |
| EPS (Diluted) | — | -$0.23-169.7% | $0.33+230.0% | $0.10-52.4% | $0.21+600.0% | $0.03+102.6% | -$1.14-1136.4% | $0.11-35.3% | $0.17-48.5% | $0.33+94.1% | $0.17+160.7% | -$0.28-47.4% | -$0.19-171.4% | -$0.07-800.0% | $0.01-90.9% | $0.11 |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AMS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $55.5M-7.8% | $60.2M+25.0% | $48.2M+9.6% | $44.0M-3.2% | $45.4M+4.1% | $43.7M-18.8% | $53.8M-6.5% | $57.5M-1.2% | $58.2M-4.0% | $60.6M+12.0% | $54.1M-19.9% | $67.5M-5.9% | $71.7M-2.2% | $73.3M-1.6% | $74.5M |
| Current Assets | $17.7M-32.5% | $26.3M+28.4% | $20.5M+9.3% | $18.7M+24.1% | $15.1M+39.1% | $10.8M+1.0% | $10.7M+8.0% | $9.9M+11.8% | $8.9M+13.1% | $7.9M+30.9% | $6.0M-57.8% | $14.2M+84.9% | $7.7M+10.8% | $7.0M-60.5% | $17.6M |
| Cash & Equivalents | $3.5M-68.6% | $11.0M-19.5% | $13.7M+11.0% | $12.3M+51.4% | $8.1M+105.6% | $4.0M+177.2% | $1.4M-0.9% | $1.4M-33.0% | $2.2M-25.0% | $2.9M+30.0% | $2.2M+108.6% | $1.1M-44.5% | $1.9M+22.1% | $1.6M-39.4% | $2.6M |
| Accounts Receivable | $10.5M-9.4% | $11.6M+167.3% | $4.3M+14.3% | $3.8M-9.7% | $4.2M-2.1% | $4.3M-37.6% | $6.9M+25.3% | $5.5M+9.6% | $5.0M+22.9% | $4.1M+34.5% | $3.0M-4.8% | $3.2M-29.4% | $4.5M+22.0% | $3.7M-19.5% | $4.6M |
| Goodwill | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $27.8M-7.9% | $30.2M+37.9% | $21.9M+19.4% | $18.3M-13.5% | $21.2M-13.1% | $24.4M-12.1% | $27.8M-14.4% | $32.4M-5.6% | $34.3M-12.2% | $39.1M+15.1% | $34.0M-26.3% | $46.1M-11.5% | $52.1M+15.3% | $45.2M-16.8% | $54.3M |
| Current Liabilities | $23.4M+125.3% | $10.4M-3.5% | $10.8M+108.3% | $5.2M-12.2% | $5.9M-52.4% | $12.4M+50.7% | $8.2M-13.3% | $9.5M+5.2% | $9.0M+3.8% | $8.7M-0.2% | $8.7M-46.5% | $16.3M+37.9% | $11.8M+22.1% | $9.7M-2.9% | $9.9M |
| Long-Term Debt | $0-100.0% | $17.3M+57.1% | $11.0M-9.5% | $12.2M-14.8% | $14.3M+316.4% | $3.4M+76.0% | $2.0M-41.4% | $3.3M-7.4% | $3.6M-29.5% | $5.1M-46.8% | $9.6M-10.5% | $10.7M-31.0% | $15.5M-12.5% | $17.8M+15.6% | $15.4M |
| Total Equity | $24.0M-4.6% | $25.2M+11.3% | $22.6M+4.6% | $21.6M+8.7% | $19.9M+3.2% | $19.3M-26.0% | $26.0M+3.7% | $25.1M+5.2% | $23.9M+11.0% | $21.5M+6.8% | $20.1M-6.0% | $21.4M+9.2% | $19.6M-1.6% | $19.9M-1.4% | $20.2M |
| Retained Earnings | $4.3M-26.7% | $5.8M+60.2% | $3.6M+20.2% | $3.0M+78.5% | $1.7M+13.0% | $1.5M-82.5% | $8.6M+8.3% | $7.9M+14.9% | $6.9M+38.8% | $5.0M+23.1% | $4.0M-27.5% | $5.5M-14.7% | $6.5M-4.6% | $6.8M+0.6% | $6.8M |
Not reported in any period shown, so not listed: Inventory.
AMS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.4M | $3.1M+1755.1% | $167K-97.1% | $5.7M-21.0% | $7.2M+15.4% | $6.3M-35.7% | $9.7M+21.1% | $8.0M-0.2% | $8.1M+2.7% | $7.9M-6.3% | $8.4M-2.0% | $8.5M+26.2% | $6.8M-16.1% | $8.1M+17.6% | $6.9M+0.3% | $6.8M |
| Capital Expenditures | $1.8M | $7.6M-3.8% | $7.9M+26.5% | $6.3M+1516.8% | $388K-76.8% | $1.7M+267.9% | $455K-54.0% | $990K-37.2% | $1.6M+96.4% | $803K-22.9% | $1.0M+15.8% | $900K-82.7% | $5.2M+204.8% | $1.7M-74.2% | $6.6M+18.2% | $5.6M |
| Free Cash Flow | -$433K | -$4.5M+41.6% | -$7.8M-1300.2% | -$555K-108.1% | $6.8M+49.1% | $4.6M-50.6% | $9.3M+31.6% | $7.1M+8.8% | $6.5M-8.0% | $7.0M-3.9% | $7.3M-4.1% | $7.6M+389.9% | $1.6M-75.5% | $6.4M+2608.9% | $235K-81.0% | $1.2M |
| Investing Cash Flow | -$1.8M | -$7.6M-7.4% | -$7.1M-13.3% | -$6.3M-1516.8% | -$388K+76.8% | -$1.7M+29.9% | -$2.4M-141.3% | -$990K+35.1% | -$1.5M-133.7% | -$653K+37.3% | -$1.0M-14.5% | -$910K | N/A | -$1.7M+74.1% | -$6.7M-17.9% | -$5.7M |
| Financing Cash Flow | -$8.1M | -$3.0M-168.7% | $4.4M+130.6% | $1.9M+171.9% | -$2.7M-305.6% | -$655K+86.4% | -$4.8M+32.0% | -$7.1M+2.4% | -$7.2M+7.3% | -$7.8M-20.8% | -$6.5M+0.2% | -$6.5M | N/A | -$6.0M-392.6% | -$1.2M-4113.8% | -$29K |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $2K | $0-100.0% | $28K | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AMS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.0%-14.4pp | 32.4%-11.4pp | 43.8%+1.4pp | 42.4%+4.3pp | 38.2%+13.1pp | 25.0%-8.5pp | 33.6%-4.4pp | 38.0%-6.3pp | 44.3%-2.7pp | 47.0%+6.5pp | 40.6%+6.3pp | 34.2%-5.2pp | 39.5%-1.2pp | 40.6%+4.7pp | 36.0% |
| Operating Margin | -12.8%-2.9pp | -9.9%-11.2pp | 1.3%-11.0pp | 12.3%+4.7pp | 7.7%+60.7pp | -53.0%-60.5pp | 7.5%-2.0pp | 9.4%-2.9pp | 12.3%-5.2pp | 17.6%+5.6pp | 12.0%+12.3pp | -0.3%-6.7pp | 6.4%+2.1pp | 4.3%-2.9pp | 7.1% |
| Net Margin | -5.5%-13.2pp | 7.7%+4.9pp | 2.9%-3.9pp | 6.7%+5.6pp | 1.1%+40.7pp | -39.6%-42.8pp | 3.2%-2.0pp | 5.2%-4.6pp | 9.8%+4.9pp | 5.0%+14.2pp | -9.2%-3.0pp | -6.2%-4.4pp | -1.8%-2.0pp | 0.2%-2.1pp | 2.3% |
| Return on Equity | -6.5%-15.1pp | 8.7%+6.0pp | 2.7%-3.4pp | 6.1%+5.2pp | 1.0%+37.6pp | -36.6%-39.1pp | 2.5%-1.6pp | 4.1%-4.0pp | 8.1%+3.7pp | 4.3%+11.9pp | -7.6%-3.1pp | -4.4%-2.9pp | -1.6%-1.8pp | 0.2%-2.3pp | 2.5% |
| Return on Assets | -2.8%-6.4pp | 3.6%+2.4pp | 1.3%-1.8pp | 3.0%+2.6pp | 0.4%+16.6pp | -16.2%-17.4pp | 1.2%-0.5pp | 1.8%-1.5pp | 3.3%+1.8pp | 1.5%+4.3pp | -2.8%-1.4pp | -1.4%-1.0pp | -0.4%-0.5pp | 0.1%-0.6pp | 0.7% |
| Current Ratio | 0.76-1.8x | 2.52+0.6x | 1.90-1.7x | 3.62+1.1x | 2.56+1.7x | 0.88-0.4x | 1.31+0.3x | 1.05+0.1x | 0.99+0.1x | 0.91+0.2x | 0.69-0.2x | 0.88+0.2x | 0.65-0.1x | 0.72-1.1x | 1.77 |
| Debt-to-Equity | 0.00-0.7x | 0.69+0.2x | 0.49-0.1x | 0.56-0.2x | 0.72+0.5x | 0.18+0.1x | 0.08-0.1x | 0.130.0x | 0.15-0.1x | 0.24-0.2x | 0.480.0x | 0.50-0.3x | 0.79-0.1x | 0.89+0.1x | 0.76 |
| FCF Margin | -16.2%+11.3pp | -27.4%-24.8pp | -2.6%-37.3pp | 34.7%+8.6pp | 26.1%-26.0pp | 52.1%+17.8pp | 34.3%+1.4pp | 32.9%-3.1pp | 36.0%-3.2pp | 39.2%-7.0pp | 46.2%+36.1pp | 10.1%-26.1pp | 36.2%+34.8pp | 1.4%-4.2pp | 5.6% |
Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
